Clinical Trial Update: Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial update on preventing cognitive decline in African Americans with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Thomas Jefferson University | Conditions: Mild Cognitive Impairment (MCI) | Phase 3 | Status: COMPLETED | Results posted: 2018-11-20